Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Consumer Staples

Kenvue Inc. (KVUE)

NYQ · Household & Personal Products

$19.75+0.27 (+1.39%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$37.92B
P/E (TTM)
23.24
EPS
$0.85
Div Yield
4.26%
52W Range
$14.02–$22.44
Beta
0.44

Company overview

Next earnings: 2026-08-06(9d)

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Peers in Household & Personal Products

All in industry →

Recent press releases

Kenvue Inc. has not issued a press release in this window.

SEC filings

All filings →

Kenvue Inc. has not filed an SEC document in this window.

Kenvue Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
68,470,600 sh+103.3%
2,344,087 sh-93.1%
3,310,000 sh-89.2%
26,620,839 sh+1891.3%
159,550,592 sh+10.2%
48,146,476 sh+56.3%
41,856,272 sh+69.5%
24,330,463 sh+293.4%

People at Kenvue Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$1.10B
NI $322.0M
06/25
$1.55B
NI $14.0M
09/25
$3.76B
NI $398.0M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.21
Prior: $0.22
Revenue sparkline